Ixazomib Named MLN9708 MLN-9708 MLN 9708 1201902-80-8

Basic Info

Model No.: 1201902-80-8

Additional Info

Packaging: AS REQUIRED

Productivity: KGS

Brand: VOLSENCHEM

Transportation: Air

Place of Origin: CHINA

Supply Ability: TRUE MANUFACTURER

Certificate: ISO

Product Description

Ixazomib1201902-80-8 is Proteasome inhibitor which has a shorter proteasome dissociation half-life and improved pharmacokinetics, pharmacodynamics, and antitumor effort compared with bortezomib. Ixazomib CAS 1201902-80-8 also known as ixazomib citrate, is a prodrug of Ixazomib (MMLN-2238). We are the good manufacturer and supplier of Ixazomib in China, stable commercial making for several batches in perfect quality. Welcome to contact us to get more details of Ixazomib.

Thera. Category: Anti-cancer

Cas No.: 1201902-80-8

Synonym: 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid;MLN9708;MLN9708,MLN-9708,MLN 9708;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid;4-Carboxy-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-acetic acid MLN9708;Ixazomib Citrate

Molecular Formula:  C20H23BCl2N2O9

Molecular Weight: 303.31802

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage:

MLN9708 CAS 1201902-80-8 is a selective, potent, and reversible proteasome inhibitor.

1) Ixazomib 1201902-80-8

2) Ixazomib Citrate (MLN9708) CAS 1239908-20-3

3) Ixazomib(MLN-2238; MLN 2238; MLN2238) CAS 1072833-77-2